SCHEMBL4537386

SCHEMBL4537386

OCCCC(O)Cc1cccc(O)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 1/20 0.44
DRD2 P14416 1/20 0.42
DRD1 P21728 1/20 0.42
TAAR1 Q96RJ0 1/20 0.42
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
PKM P14618 1/20 0.41
ALOX15 P16050 1/20 0.41
NFKB1 P19838 1/20 0.41
MAPK1 P28482 1/20 0.41
OPRM1 P35372 2/20 0.40
OPRD1 P41143 2/20 0.40
OPRK1 P41145 2/20 0.40
KMT2A Q03164 1/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
BLM P54132 1/20 0.40
PMP22 Q01453 1/20 0.40
GRIA2 P42262 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14402697 0.85 OPRM1 (0.47) ENPP2DRD2DRD1OPRM1OPRD1
SCHEMBL7791226 0.82 ENPP2 (0.50) ENPP2DRD2DRD1TAAR1CYP1A2
SCHEMBL14402413 0.81 DRD2 (0.47) ENPP2DRD2DRD1TAAR1OPRM1
SCHEMBL13850025 0.81 DRD2 (0.47) ENPP2DRD2DRD1TAAR1OPRM1
SCHEMBL14402391 0.81 DRD2 (0.47) ENPP2DRD2DRD1TAAR1OPRM1
SCHEMBL4964239 0.80 TRPA1 (0.44) CYP1A2PKM
SCHEMBL4964246 0.80 TRPA1 (0.44) CYP1A2PKM
SCHEMBL875439 0.80 TRPA1 (0.44) CYP1A2PKM
SCHEMBL2853387 0.78 FOLH1 (0.55)
SCHEMBL29185405 0.77 ENPP2 (0.46) ENPP2DRD2DRD1TAAR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2846788-A1 USE OF COMPOUNDS FOR THE TREATMENT OF PAIN Akron Molecules AG (AT) 2015-03-18 EP disclosed
WO-2013167743-A1 USE OF COMPOUNDS FOR THE TREATMENT OF PAIN AKRON MOLECULES GMBH (AT) 2013-11-14 WO disclosed
EP-2637649-A2 COMPOUNDS AND METHODS FOR TREATING PAIN Akron Molecules GmbH (AT) 2013-09-18 EP disclosed
WO-2012062925-A2 COMPOUNDS AND METHODS FOR TREATING PAIN AKRON MOLECULES GMBH (AT) 2012-05-18 WO disclosed